rs560246798
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_015311.3(OBSL1):c.3341G>A(p.Trp1114*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,612,542 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 34) 
 Exomes 𝑓:  0.000038   (  0   hom.  ) 
Consequence
 OBSL1
NM_015311.3 stop_gained
NM_015311.3 stop_gained
Scores
 5
 1
 1
Clinical Significance
Conservation
 PhyloP100:  7.85  
Publications
4 publications found 
Genes affected
 OBSL1  (HGNC:29092):  (obscurin like cytoskeletal adaptor 1) Cytoskeletal adaptor proteins function in linking the internal cytoskeleton of cells to the cell membrane. This gene encodes a cytoskeletal adaptor protein, which is a member of the Unc-89/obscurin family. The protein contains multiple N- and C-terminal immunoglobulin (Ig)-like domains and a central fibronectin type 3 domain. Mutations in this gene cause 3M syndrome type 2. Alternatively spliced transcript variants encoding different isoforms have been found in this gene. [provided by RefSeq, Mar 2010] 
OBSL1 Gene-Disease associations (from GenCC):
- 3M syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
 - 3-M syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152260Hom.:  0  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152260
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000126  AC: 31AN: 245354 AF XY:  0.000127   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
31
AN: 
245354
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000384  AC: 56AN: 1460164Hom.:  0  Cov.: 35 AF XY:  0.0000454  AC XY: 33AN XY: 726362 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
56
AN: 
1460164
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
33
AN XY: 
726362
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33452
American (AMR) 
 AF: 
AC: 
0
AN: 
44608
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26072
East Asian (EAS) 
 AF: 
AC: 
54
AN: 
39674
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86028
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52662
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5760
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111568
Other (OTH) 
 AF: 
AC: 
2
AN: 
60340
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.467 
Heterozygous variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152378Hom.:  0  Cov.: 34 AF XY:  0.0000268  AC XY: 2AN XY: 74522 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152378
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
2
AN XY: 
74522
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41594
American (AMR) 
 AF: 
AC: 
0
AN: 
15314
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
3
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68024
Other (OTH) 
 AF: 
AC: 
0
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
20
Asia WGS 
 AF: 
AC: 
2
AN: 
3478
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Uncertain:2 
Nov 19, 2018
Center for Personalized Medicine, Children's Hospital Los Angeles
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 22, 2019
Knight Diagnostic Laboratories, Oregon Health and Sciences University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Pathogenic 
D 
 PhyloP100 
 Vest4 
 ClinPred 
T 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.